Inventor · disambiguated record
Gopinadh Bhyrapuneni
Also filed as: BHYRAPUNENI GOPINADH
13 granted patents·3 pending applications·22 citations·filing 2009–2024
86Inventor score
Top patents by PatentIndex Score
16 records- 0189US9957257B2Amide compounds as 5-HT4 receptor agonistsSUVEN LIFE SCIENCES LTD·Filed 2016·Granted May 1, 2018·12 cites·9 claims
- 0278US9079894B2Heteroaryl compounds as 5-HT4 receptor ligandsNIROGI RAMAKRISHNA·Filed 2012·Granted Jul 14, 2015·5 cites·14 claims
- 0377US2024277690A1New uses of a 5-ht4 receptor agonistSUVEN LIFE SCIENCES LTD·Filed 2024·Application pending·0 cites
- 0477US2024293389A1Method of treating cognitive deficits associated with schizophreniaSUVEN LIFE SCIENCES LTD·Filed 2024·Application pending·0 cites
- 0575US10294217B2Fluoroindole derivatives as muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2016·Granted May 21, 2019·1 cites·8 claims
- 0673US11040026B2Muscarinic M1 receptor positive allosteric modulatorsSUVEN LIFE SCIENCES LTD·Filed 2017·Granted Jun 22, 2021·1 cites·16 claims
- 0771US12285421B2Uses of a 5-HT4 receptor agonistSUVEN LIFE SCIENCES LTD·Filed 2019·Granted Apr 29, 2025·0 cites·4 claims
- 0871US8735423B2Bicyclic compounds as α4β2 nicotinic acetylcholine receptor ligandsNIROGI RAMAKRISHNA·Filed 2009·Granted May 27, 2014·2 cites·8 claims
- 0966US9636335B2Heteroaryl compounds as 5-HT4 receptor ligandsSUVEN LIFE SCIENCES LTD·Filed 2015·Granted May 2, 2017·1 cites·21 claims
- 1053US8598204B21,2-dihydro-2-oxoquinoline compounds as 5-HT4 receptor ligandsNIROGI RAMAKRISHNA·Filed 2009·Granted Dec 3, 2013·0 cites·6 claims
- 1152US8404720B2Aryl sulfonamide amine compounds and their use as 5-HT6 ligandsNIROGI RAMAKRISHNA·Filed 2009·Granted Mar 26, 2013·0 cites·11 claims
- 1249US11458135B2Combination of pure 5-HT6 receptor antagonists with acetylcholinesterase inhibitorsSUVEN LIFE SCIENCES LTD·Filed 2016·Granted Oct 4, 2022·0 cites·38 claims
- 1348US11116764B2Combination of pure 5-HT6 receptor antagonists with NMDA receptor antagonistSUVEN LIFE SCIENCES LTD·Filed 2016·Granted Sep 14, 2021·0 cites·24 claims
- 1447US11253514B2Triple combination of pure 5-HT6 receptor antagonists, acetylcholinesterase inhibitors and NMDA receptor antagonistSUVEN LIFE SCIENCES LTD·Filed 2016·Granted Feb 22, 2022·0 cites·16 claims
- 1543US10603323B2Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitorsSUVEN LIFE SCIENCES LTD·Filed 2017·Granted Mar 31, 2020·0 cites·26 claims
- 1641US2019336509A1Triple combination of histamine-3 receptor inverse agonists, acetylcholinesterase inhibitors and nmda receptor antagonistSUVEN LIFE SCIENCES LTD·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →